Assessment of human cancer risk: Challenges for alternative approaches

Toxicologic Pathology

Volumn 29, Issue SUPPL., 2001, Pages 5-12

  Omenn, G S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancer risk assessment; Cost effectiveness analysis; Public health context; Risk management; Social costs; Value of information model

Indexed keywords

ANIMAL MODEL; BIOASSAY; CANCER RISK; CARCINOGEN TESTING; CARCINOGENESIS; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC VALUE; EPIDEMIOLOGICAL DATA; PRIORITY JOURNAL; REGULATORY MECHANISM; RELIABILITY; RISK ASSESSMENT; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY;

ACADEMIES AND INSTITUTES; ANIMAL TESTING ALTERNATIVES; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; COST-BENEFIT ANALYSIS; EDUCATION; HUMANS; INTERNATIONAL COOPERATION; MICE; NEOPLASMS, EXPERIMENTAL; RATS; RISK ASSESSMENT;

ANIMALIA; RODENTIA;

EID: 0034750392     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301753178429     Document Type: Conference Paper

References (25)

1. Prediction of rodent carcinogenicity of 44 chemicals: Results
2. Identification, characterization, and control of potential human carcinogens: A framework for federal decision-making
3. Risk assessment
4. Supplement to the carcinogenic potency database (CPDB): Results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996
5. What do animal cancer tests tell us about human cancer risk? Overview of analyses of the carcinogenic potency database
6. The environment and disease: Association or causation?
7. Draft guideline on testing for carcinogenicity of pharmaceuticals
8. Information value of the rodent bioassay
9. Cost-effectiveness of short-term tests for carcinogenicity
10. Mechanistic considerations in the regulation and classification of chemical carcinogens
11. The post-genomic era: A crucial role for the public health sciences
12. Risk assessment and risk management
13. Scientific and cost-effectiveness criteria in selecting batteries of short-term tests
14. Predictions of rodent carcinogenicity testing results: Interpretation in light of the Lave-Omenn value-of-information model
15. Comparison of rat liver foci assay and strain A mouse lung tumor assay to detect carcinogens: A review
16. International Life Sciences Institute's role in the evaluation of alternative methodology for the assessment of carcinogenic risk
17. Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the U S National Toxicology Program